QHSLab reports Oct sales up 110% to $225k; APA abstracts accepted for 2025

QHSLab, Inc.

October 2024 unaudited sales ~$225,000, a 110% increase YoY; annualized run rate $2.7M.
Two research abstracts accepted for presentation at 2025 APA Annual Meeting in Los Angeles.
DMAR study (allergic rhinitis) reached second milestone; participant recruitment exceeded projections.
Company highlights reductions in symptom severity and improved quality of life in mental health studies.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.